Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer

por Pirlog, Cristina-Florina, Cotan, Horia Teodor, Parosanu, Andreea, Orlov Slavu, Cristina, Popa, Ana Maria, Iaciu, Cristian, Olaru, Mihaela, Oprita, Alexandru Vlad, Nita, Irina, Nitipir, Cornelia
Publicado 2022

Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?

por Pîrlog, Cristina-Florina, Costache, Raluca, Paroșanu, Andreea Ioana, Slavu, Cristina Orlov, Olaru, Mihaela, Popa, Ana Maria, Iaciu, Cristian, Niță, Irina, Moțatu, Pompilia, Cotan, Horia Teodor, Oprița, Alexandru Vlad, Costache, Daniel, Manolescu, Loredana Sabina Cornelia, Nițipir, Cornelia
Publicado 2023